LH has previously been described as a cell enhancing migration and invasion by activating regulator proteins in ovarian (Mertens-Walker et al., 2010), endometrial (Noci et al., 2008), and breast cancer (Sanchez et al., 2016). The gene discussed is PLOD1; the disease is breast carcinoma.